Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit

June 04, 2025
REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%. The forecast signal date was March 14, 2025, with a price of $665.89 and a predicted direction of short. On June 4, 2025, REGN reached the target price of $484.93. This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements.

Market analysis shows that REGN experienced a gradual decline in price leading up to the target date, with various factors contributing to this downward movement. The pharmaceutical industry faced challenges such as regulatory changes, competition, and market volatility during this period, impacting REGN's stock performance. QuantWave's forecast took into account these market conditions and provided users with valuable insights to make informed investment decisions.

QuantWave offers users access to forecasts for a wide range of stocks, presenting opportunities for potential profits through its automated platform. For investors seeking to enhance their understanding of QuantWave's forecasting system, QuantSchool offers educational resources on professional investment strategies. QuantSchool delves into the key principles for generating consistent income using QuantWave's analytics, empowering users to make smarter investment choices.

Overall, the successful prediction of REGN's price target by QuantWave demonstrates the platform's reliability in forecasting stock movements and maximizing returns for investors.
If you want to leave a comment, then you need Login or Register





Other data for REGN

Related data

REGNSeptember 5, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) has been making waves in the stock market recently, with Evercore ISI maintaining a buy rating and a price target of 750....


REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


REGNJune 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target  ~1 min.

Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits 30.6% Profit Target as Forecasted by QuantWave  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 30.6%....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.63% Profit: QuantWave Analysis  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, yielding a profit of 17.63%....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target Forecast with a Profit of 17.34%  ~1 min.

On January 23, 2025, QuantWave, the automated forecasting platform, issued a short forecast signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at 692.73 $....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....